Photocontrolled activation of doubly o -nitrobenzyl-protected small molecule benzimidazoles leads to cancer cell death.
Manzoor AhmadNaveen J RoyAnurag SinghDebashis MondalAbhishek MondalThangavel VijayakanthMayurika LahiriPinaki TalukdarPublished in: Chemical science (2023)
Artificial biomimetic chloride anionophores have shown promising applications as anticancer scaffolds. Importantly, stimuli-responsive chloride transporters that can be selectively activated inside the cancer cells to avoid undesired toxicity to normal, healthy cells are very rare. Particularly, light-responsive systems promise better applicability for photodynamic therapy because of their spatiotemporal controllability, low toxicity, and high tunability. Here, in this work, we report o -nitrobenzyl-linked, benzimidazole-based singly and doubly protected photocaged protransporters 2a, 2b, 3a, and 3b, respectively, and benzimidazole-2-amine-based active transporters 1a-1d. Among the active compounds, trifluoromethyl -based anionophore 1a showed efficient ion transport activity (EC 50 = 1.2 ± 0.2 μM). Detailed mechanistic studies revealed Cl - /NO 3 - antiport as the main ion transport process. Interestingly, double protection with photocages was found to be necessary to achieve the complete "OFF-state" that could be activated by external light. The procarriers were eventually activated inside the MCF-7 cancer cells to induce phototoxic cell death.
Keyphrases
- cell death
- cell cycle arrest
- small molecule
- photodynamic therapy
- molecular docking
- oxidative stress
- induced apoptosis
- cancer therapy
- papillary thyroid
- tissue engineering
- machine learning
- single cell
- squamous cell carcinoma
- breast cancer cells
- big data
- endoplasmic reticulum stress
- deep learning
- drug delivery
- case control
- childhood cancer